Abstract 329: Hyperactivation of Mtorc1 Drives Acquired Resistance to the Pan-Her Tyrosine Kinase Inhibitor Neratinib in HER2-mutant Cancers
Cancer research(2019)
Key words
HER2,Cancer,Receptor Tyrosine Kinase
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined